FDA Clarifies Approval Pathways for Applications in New Draft Guidance By Sam | November 16, 2017 In a new draft guidance, the FDA describes which abbreviated approval pathways are available for ANDAs and 505(b)(2) applications. Source: Generic Line Posted in Generic Line